Medicon Village Investor Panel connects life science companies with leading investors

Last Wednesday, Medicon Village hosted its very first Medicon Village Investor Panel, bringing together eight innovative life science companies with a distinguished panel of Nordic and international investors.
The initiative aims to strengthen investment readiness among early- and growth-stage companies while creating a platform for meaningful dialogue between entrepreneurs and investors.
The selected Medicon Village-based companies – MedVasc, Paindrainer, PharmNovo, Reccan, Respiratorius, Strike Pharma, Suturion and Targinta – span pharma, biotech, medtech, diagnostics and digital health, showcasing the breadth of innovation within the Medicon Village ecosystem.
The investor panel featured representatives from leading venture capital firms and investment organisations such as Linc, EQT, Navigare Ventures and Segulah Medical Acceleration. The event included company pitches followed by in-depth Q&A sessions with the panel, designed to provide both visibility and valuable feedback. In the run-up, participating companies benefited from tailored pitch preparation to maximise the opportunity.
“The Medicon Village Investor Panel really captures what Medicon Village is about – creating connections that help great science turn into innovations that reach the market and benefit society. Seeing investors and entrepreneurs so engaged in meaningful dialogue during the day gives me confidence that new partnerships and opportunities will follow,” says Sarah Lidé, Deputy CEO of Medicon Village Innovation.
“Drawing on my experience in corporate finance and as an active investor, I see great value in initiatives like the Medicon Village Investor Panel. It connects investors with promising companies and gives entrepreneurs the opportunity to gain valuable feedback and visibility,” says Markus Neuding, owner of Sedermera Corporate Finance and a permanent member of the panel.
“The Investor Panel fills an important gap in the regional ecosystem. We have many promising companies, but investors haven’t been as present as the level of interest would suggest. This format clearly met a real need. The timing, the setup and the focus were all highly appreciated by investors and companies,” says Francesco Bez, Innovation Manager at Medicon Village Innovation.
By fostering access to capital – alongside its broader mission to strengthen competence and commercialisation – Medicon Village continues to drive the growth of the regional life science cluster and its global competitiveness.
More information
For more information, visit: mediconvillage.se/medicon-village-investor-panel or feel free to contact:
- Sarah Lidé, Deputy CEO, Medicon Village Innovation, sarah.lide@mediconvillage.se
- Francesco Bez, Innovation Manager, Medicon Village Innovation, francesco.bez@mediconvillage.se
Pictured
Pictured, from left to right:
- Andreas Grape, Co-founder and CEO of Nordic Angels.
- Johan Kördel, Co-founder and Managing Partner at Sound Bioventures.
- Hugo Mörse, Partner at Bonit Capital and Managing Director of Leksell Social Ventures.
- Lovisa Backemar, Partner at Eir Ventures.
- Christer Fåhraeus, serial entrepreneur and founder and General Partner of Fåhraeus Startup & Growth (FSG).
- Erika Henriksson, Partner, EQT.
- Elin Almstedt, Principal, Navigare Ventures.
- Ann-Charlotte Beckman, serial entrepreneur and investor with over 30 years of experience in Life Science.
- Bengt Julander, Chairman and founder of Linc.
- Maria Tell, COO and Investment Director at Segulah Medical Acceleration.
- Sebastian Hodel, Managing Partner at Gainbridge Capital Partners.
- Markus Neuding, owner of Sedermera Corporate Finance.
- Sarah Lidé, Deputy CEO, Medicon Village Innovation.
- Francesco Bez, Innovation Manager, Medicon Village Innovation.
Photo: Kristian Waldeck, WalmedPhoto.